▶ 調査レポート

世界の医療用微結晶性セルロース市場予測(~2028年):木材パルプ系、精製綿系

• 英文タイトル:Global Medical Grade Microcrystalline Cellulose Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の医療用微結晶性セルロース市場予測(~2028年):木材パルプ系、精製綿系 / Global Medical Grade Microcrystalline Cellulose Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22F19798資料のイメージです。• レポートコード:GIR-22F19798
• 出版社/出版日:GlobalInfoResearch / 2022年11月
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「Global Medical Grade Microcrystalline Cellulose Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
グローバルインフォリサーチ社の最新の調査によると、世界の医療用微結晶性セルロースの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

医療用微結晶性セルロース市場はタイプ(種類)とアプリケーション(用途)によって区分されます。2017年~2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・木材パルプ系、精製綿系

アプリケーション別セグメントは次のように区分されます。
・カプセル、錠剤、その他

世界の医療用微結晶性セルロース市場の主要な市場プレーヤーは以下のとおりです。
・DuPont、JRS、Mingtai、Asahi Kasei、Accent Microcell、Sigachi、Wei Ming Pharmaceutical、Roquette、Anhui Sunhere Pharmaceutical、Linghu Xinwang Chemical、Shandong Guangda

地域別セグメントは次の地域・国をカバーします。
・北米市場(米国、カナダ、メキシコ)
・ヨーロッパ市場(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋市場(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南米市場(ブラジル、アルゼンチン、コロンビア)
・中東・アフリカ市場(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、医療用微結晶性セルロース製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医療用微結晶性セルロースメーカーの企業概要、2019年~2022年までの医療用微結晶性セルロースの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医療用微結晶性セルロースメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別医療用微結晶性セルロースの販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの医療用微結晶性セルロースのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での医療用微結晶性セルロース市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医療用微結晶性セルロースの産業チェーンを掲載しています。
・第13、14、15章では、医療用微結晶性セルロースの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 医療用微結晶性セルロースの概要
- タイプ別分析(2017年vs2021年vs2028年):木材パルプ系、精製綿系
- アプリケーション別分析(2017年vs2021年vs2028年):カプセル、錠剤、その他
- 世界の医療用微結晶性セルロース市場規模・予測
- 世界の医療用微結晶性セルロース生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- DuPont、JRS、Mingtai、Asahi Kasei、Accent Microcell、Sigachi、Wei Ming Pharmaceutical、Roquette、Anhui Sunhere Pharmaceutical、Linghu Xinwang Chemical、Shandong Guangda
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・タイプ別分析2017年-2028年:木材パルプ系、精製綿系
・アプリケーション別分析2017年-2028年:カプセル、錠剤、その他
・医療用微結晶性セルロースの北米市場分析
- 医療用微結晶性セルロースの北米市場:タイプ別市場規模2017年-2028年
- 医療用微結晶性セルロースの北米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・医療用微結晶性セルロースのヨーロッパ市場分析
- :医療用微結晶性セルロースのヨーロッパ市場:タイプ別市場規模2017年-2028年
- :医療用微結晶性セルロースのヨーロッパ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・医療用微結晶性セルロースのアジア太平洋市場分析
- 医療用微結晶性セルロースのアジア太平洋市場:タイプ別市場規模2017年-2028年
- 医療用微結晶性セルロースのアジア太平洋市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医療用微結晶性セルロースの南米市場分析
- 医療用微結晶性セルロースの南米市場:タイプ別市場規模2017年-2028年
- 医療用微結晶性セルロースの南米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・医療用微結晶性セルロースの中東・アフリカ市場分析
- 医療用微結晶性セルロースの中東・アフリカ市場:タイプ別市場規模2017年-2028年
- 医療用微結晶性セルロースの中東・アフリカ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Medical Grade Microcrystalline Cellulose market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Medical Grade Microcrystalline Cellulose market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Capsule accounting for % of the Medical Grade Microcrystalline Cellulose global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Wood Pulp Based segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Medical Grade Microcrystalline Cellulose include DuPont, JRS, Mingtai, Asahi Kasei, and Accent Microcell, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Medical Grade Microcrystalline Cellulose market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Wood Pulp Based
Refined Cotton Based
Market segment by Application can be divided into
Capsule
Tablet
Other
The key market players for global Medical Grade Microcrystalline Cellulose market are listed below:
DuPont
JRS
Mingtai
Asahi Kasei
Accent Microcell
Sigachi
Wei Ming Pharmaceutical
Roquette
Anhui Sunhere Pharmaceutical
Linghu Xinwang Chemical
Shandong Guangda
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Grade Microcrystalline Cellulose product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Medical Grade Microcrystalline Cellulose, with price, sales, revenue and global market share of Medical Grade Microcrystalline Cellulose from 2019 to 2022.
Chapter 3, the Medical Grade Microcrystalline Cellulose competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Grade Microcrystalline Cellulose breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Medical Grade Microcrystalline Cellulose market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Medical Grade Microcrystalline Cellulose.
Chapter 13, 14, and 15, to describe Medical Grade Microcrystalline Cellulose sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Medical Grade Microcrystalline Cellulose Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Medical Grade Microcrystalline Cellulose Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Wood Pulp Based
1.2.3 Refined Cotton Based
1.3 Market Analysis by Application
1.3.1 Overview: Global Medical Grade Microcrystalline Cellulose Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Capsule
1.3.3 Tablet
1.3.4 Other
1.4 Global Medical Grade Microcrystalline Cellulose Market Size & Forecast
1.4.1 Global Medical Grade Microcrystalline Cellulose Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Medical Grade Microcrystalline Cellulose Sales in Volume (2017-2028)
1.4.3 Global Medical Grade Microcrystalline Cellulose Price (2017-2028)
1.5 Global Medical Grade Microcrystalline Cellulose Production Capacity Analysis
1.5.1 Global Medical Grade Microcrystalline Cellulose Total Production Capacity (2017-2028)
1.5.2 Global Medical Grade Microcrystalline Cellulose Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Medical Grade Microcrystalline Cellulose Market Drivers
1.6.2 Medical Grade Microcrystalline Cellulose Market Restraints
1.6.3 Medical Grade Microcrystalline Cellulose Trends Analysis
2 Manufacturers Profiles
2.1 DuPont
2.1.1 DuPont Details
2.1.2 DuPont Major Business
2.1.3 DuPont Medical Grade Microcrystalline Cellulose Product and Services
2.1.4 DuPont Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 JRS
2.2.1 JRS Details
2.2.2 JRS Major Business
2.2.3 JRS Medical Grade Microcrystalline Cellulose Product and Services
2.2.4 JRS Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mingtai
2.3.1 Mingtai Details
2.3.2 Mingtai Major Business
2.3.3 Mingtai Medical Grade Microcrystalline Cellulose Product and Services
2.3.4 Mingtai Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Asahi Kasei
2.4.1 Asahi Kasei Details
2.4.2 Asahi Kasei Major Business
2.4.3 Asahi Kasei Medical Grade Microcrystalline Cellulose Product and Services
2.4.4 Asahi Kasei Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Accent Microcell
2.5.1 Accent Microcell Details
2.5.2 Accent Microcell Major Business
2.5.3 Accent Microcell Medical Grade Microcrystalline Cellulose Product and Services
2.5.4 Accent Microcell Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sigachi
2.6.1 Sigachi Details
2.6.2 Sigachi Major Business
2.6.3 Sigachi Medical Grade Microcrystalline Cellulose Product and Services
2.6.4 Sigachi Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Wei Ming Pharmaceutical
2.7.1 Wei Ming Pharmaceutical Details
2.7.2 Wei Ming Pharmaceutical Major Business
2.7.3 Wei Ming Pharmaceutical Medical Grade Microcrystalline Cellulose Product and Services
2.7.4 Wei Ming Pharmaceutical Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Roquette
2.8.1 Roquette Details
2.8.2 Roquette Major Business
2.8.3 Roquette Medical Grade Microcrystalline Cellulose Product and Services
2.8.4 Roquette Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Anhui Sunhere Pharmaceutical
2.9.1 Anhui Sunhere Pharmaceutical Details
2.9.2 Anhui Sunhere Pharmaceutical Major Business
2.9.3 Anhui Sunhere Pharmaceutical Medical Grade Microcrystalline Cellulose Product and Services
2.9.4 Anhui Sunhere Pharmaceutical Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Linghu Xinwang Chemical
2.10.1 Linghu Xinwang Chemical Details
2.10.2 Linghu Xinwang Chemical Major Business
2.10.3 Linghu Xinwang Chemical Medical Grade Microcrystalline Cellulose Product and Services
2.10.4 Linghu Xinwang Chemical Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shandong Guangda
2.11.1 Shandong Guangda Details
2.11.2 Shandong Guangda Major Business
2.11.3 Shandong Guangda Medical Grade Microcrystalline Cellulose Product and Services
2.11.4 Shandong Guangda Medical Grade Microcrystalline Cellulose Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Medical Grade Microcrystalline Cellulose Breakdown Data by Manufacturer
3.1 Global Medical Grade Microcrystalline Cellulose Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Medical Grade Microcrystalline Cellulose Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Medical Grade Microcrystalline Cellulose
3.4 Market Concentration Rate
3.4.1 Top 3 Medical Grade Microcrystalline Cellulose Manufacturer Market Share in 2021
3.4.2 Top 6 Medical Grade Microcrystalline Cellulose Manufacturer Market Share in 2021
3.5 Global Medical Grade Microcrystalline Cellulose Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Medical Grade Microcrystalline Cellulose Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Medical Grade Microcrystalline Cellulose Market Size by Region
4.1.1 Global Medical Grade Microcrystalline Cellulose Sales in Volume by Region (2017-2028)
4.1.2 Global Medical Grade Microcrystalline Cellulose Revenue by Region (2017-2028)
4.2 North America Medical Grade Microcrystalline Cellulose Revenue (2017-2028)
4.3 Europe Medical Grade Microcrystalline Cellulose Revenue (2017-2028)
4.4 Asia-Pacific Medical Grade Microcrystalline Cellulose Revenue (2017-2028)
4.5 South America Medical Grade Microcrystalline Cellulose Revenue (2017-2028)
4.6 Middle East and Africa Medical Grade Microcrystalline Cellulose Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Medical Grade Microcrystalline Cellulose Sales in Volume by Type (2017-2028)
5.2 Global Medical Grade Microcrystalline Cellulose Revenue by Type (2017-2028)
5.3 Global Medical Grade Microcrystalline Cellulose Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Medical Grade Microcrystalline Cellulose Sales in Volume by Application (2017-2028)
6.2 Global Medical Grade Microcrystalline Cellulose Revenue by Application (2017-2028)
6.3 Global Medical Grade Microcrystalline Cellulose Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Medical Grade Microcrystalline Cellulose Sales by Type (2017-2028)
7.2 North America Medical Grade Microcrystalline Cellulose Sales by Application (2017-2028)
7.3 North America Medical Grade Microcrystalline Cellulose Market Size by Country
7.3.1 North America Medical Grade Microcrystalline Cellulose Sales in Volume by Country (2017-2028)
7.3.2 North America Medical Grade Microcrystalline Cellulose Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Medical Grade Microcrystalline Cellulose Sales by Type (2017-2028)
8.2 Europe Medical Grade Microcrystalline Cellulose Sales by Application (2017-2028)
8.3 Europe Medical Grade Microcrystalline Cellulose Market Size by Country
8.3.1 Europe Medical Grade Microcrystalline Cellulose Sales in Volume by Country (2017-2028)
8.3.2 Europe Medical Grade Microcrystalline Cellulose Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Medical Grade Microcrystalline Cellulose Sales by Type (2017-2028)
9.2 Asia-Pacific Medical Grade Microcrystalline Cellulose Sales by Application (2017-2028)
9.3 Asia-Pacific Medical Grade Microcrystalline Cellulose Market Size by Region
9.3.1 Asia-Pacific Medical Grade Microcrystalline Cellulose Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Medical Grade Microcrystalline Cellulose Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Medical Grade Microcrystalline Cellulose Sales by Type (2017-2028)
10.2 South America Medical Grade Microcrystalline Cellulose Sales by Application (2017-2028)
10.3 South America Medical Grade Microcrystalline Cellulose Market Size by Country
10.3.1 South America Medical Grade Microcrystalline Cellulose Sales in Volume by Country (2017-2028)
10.3.2 South America Medical Grade Microcrystalline Cellulose Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Medical Grade Microcrystalline Cellulose Sales by Type (2017-2028)
11.2 Middle East & Africa Medical Grade Microcrystalline Cellulose Sales by Application (2017-2028)
11.3 Middle East & Africa Medical Grade Microcrystalline Cellulose Market Size by Country
11.3.1 Middle East & Africa Medical Grade Microcrystalline Cellulose Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Medical Grade Microcrystalline Cellulose Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Medical Grade Microcrystalline Cellulose and Key Manufacturers
12.2 Manufacturing Costs Percentage of Medical Grade Microcrystalline Cellulose
12.3 Medical Grade Microcrystalline Cellulose Production Process
12.4 Medical Grade Microcrystalline Cellulose Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Medical Grade Microcrystalline Cellulose Typical Distributors
13.3 Medical Grade Microcrystalline Cellulose Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer